183 related articles for article (PubMed ID: 23307955)
1. Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.
Liu H; Zhang W; Xu Z; Caldwell RW; Caldwell RB; Brooks SE
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):918-31. PubMed ID: 23307955
[TBL] [Abstract][Full Text] [Related]
2. Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model.
Zhang W; Yokota H; Xu Z; Narayanan SP; Yancey L; Yoshida A; Marcus DM; Caldwell RW; Caldwell RB; Brooks SE
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6384-95. PubMed ID: 21705685
[TBL] [Abstract][Full Text] [Related]
3. Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog.
Lutty GA; McLeod DS; Bhutto I; Wiegand SJ
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4039-47. PubMed ID: 21357392
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
5. VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP.
McColm JR; Geisen P; Hartnett ME
Mol Vis; 2004 Jul; 10():512-20. PubMed ID: 15303088
[TBL] [Abstract][Full Text] [Related]
6. Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.
Budd SJ; Thompson H; Hartnett ME
Arch Ophthalmol; 2010 Aug; 128(8):1014-21. PubMed ID: 20697002
[TBL] [Abstract][Full Text] [Related]
7. Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.
Budd S; Byfield G; Martiniuk D; Geisen P; Hartnett ME
Exp Eye Res; 2009 Nov; 89(5):718-27. PubMed ID: 19576214
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.
Geisen P; Peterson LJ; Martiniuk D; Uppal A; Saito Y; Hartnett ME
Mol Vis; 2008 Feb; 14():345-57. PubMed ID: 18334951
[TBL] [Abstract][Full Text] [Related]
9. Suppression of retinal neovascularization by the iNOS inhibitor aminoguanidine in mice of oxygen-induced retinopathy.
Zhang Q; Zhang J; Guan Y; Zhang S; Zhu C; Xu GT; Wang L
Graefes Arch Clin Exp Ophthalmol; 2009 Jul; 247(7):919-27. PubMed ID: 19301028
[TBL] [Abstract][Full Text] [Related]
10. Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis).
Hartnett ME
Trans Am Ophthalmol Soc; 2010 Dec; 108():96-119. PubMed ID: 21212851
[TBL] [Abstract][Full Text] [Related]
11. The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP.
Leske DA; Wu J; Fautsch MP; Karger RA; Berdahl JP; Lanier WL; Holmes JM
Mol Vis; 2004 Jan; 10():43-50. PubMed ID: 14758338
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat.
van Wijngaarden P; Brereton HM; Gibbins IL; Coster DJ; Williams KA
Exp Eye Res; 2007 Oct; 85(4):508-17. PubMed ID: 17692314
[TBL] [Abstract][Full Text] [Related]
13. The Nicotinic Cholinergic Pathway Contributes to Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity.
Hackett SF; Seidel C; Abraham S; Chadha R; Fortmann SD; Campochiaro PA; Cooke JP
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1296-1303. PubMed ID: 28241318
[TBL] [Abstract][Full Text] [Related]
14. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
15. Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity.
Budd SJ; Hartnett ME
Arch Ophthalmol; 2010 May; 128(5):589-95. PubMed ID: 20457980
[TBL] [Abstract][Full Text] [Related]
16. Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.
Davies MH; Zamora DO; Smith JR; Powers MR
Microvasc Res; 2009 May; 77(3):382-6. PubMed ID: 19232363
[TBL] [Abstract][Full Text] [Related]
17. The relationship of retinal VEGF and retinal IGF-1 mRNA with neovascularization in an acidosis-induced model of retinopathy of prematurity.
Leske DA; Wu J; Mookadam M; Chen Y; Fautsch MP; Holmes JM; Lanier WL
Curr Eye Res; 2006 Feb; 31(2):163-9. PubMed ID: 16500767
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
[TBL] [Abstract][Full Text] [Related]
19. RPE cells modulate subretinal neovascularization, but do not cause regression in mice with sustained expression of VEGF.
Ida H; Tobe T; Nambu H; Matsumura M; Uyama M; Campochiaro PA
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5430-7. PubMed ID: 14638748
[TBL] [Abstract][Full Text] [Related]
20. Captopril and vascular endothelial growth factor in a mouse model of retinopathy.
Higgins RD; Yan Y; Geng Y; Sharma J; Barr SM
Curr Eye Res; 2003 Aug; 27(2):123-9. PubMed ID: 14632165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
